coronavirus treatment

The effects of the coronavirus can vary dramatically from person to person. Some may have mild symptoms, while others suffer extreme symptoms and even death. AI therapeutics in Guilford is working on a drug that they say can slow those symptoms at the start. “This is an oral pill that you take, we have five million that we’re making,...

One Connecticut company is working on a drug to slow the progression of COVID-19 in people who are already infected.

Pharmaceutical giant Gilead says it plans to charge at least $2,300 for a single treatment course of Remdesivir, a drug shown to shorten recovery time for severely ill coronavirus patients.

A new study out of the University of Minnesota suggests that anti-malarial drug hydroxychloroquine has no effect on preventing patients from contracting the novel coronavirus.

It has been six months since the start of the novel coronavirus outbreak, and what we have learned about the deadly disease that upended our lives has changed considerably. Dr. Summer McGee, dean of the School of Public Health at the University of New Haven, gave her take on the evolution of our understanding of the deadly coronavirus, six months…

We look back at what we’ve learned over the last six months and what the future against the virus looks like

Results from a phase three trial show that Remdesivir helps recovery in moderately-ill coronavirus patients.

At a press conference on Monday, Admiral Brett Giroir, assistant secretary for health, confirmed that HHS is working with a network of children’s hospitals and intensive care units to better understand the extreme coronavirus symptoms in infected children.

Companies around the world are working on vaccines and treatments for the coronavirus, and that includes the Pfizer lab in Groton. They’ve already started human clinical trials of a vaccine they believe could be available as soon as September. Inside the Pfizer lab in Groton there’s a two-prong approach to defeating COVID-19: developing treatments and developing a vaccine. The...

WHO Director-General Dr. Tedros Adhanom Ghebreyesus on Monday announced 40 countries have united to pledge billions of dollars to help find a vaccine to fight the coronavirus pandemic.

When asked if he takes responsibility for the spike in calls to poison control centers around the country following his on-camera comments about bleach and disinfectant injection as a potential coronavirus treatment, President Donald Trump said, “I can’t imagine why.”

Patients with COVID-19 could see results from blood plasma treatment within days.

Trinity Health of New England is working on a clinical trial using blood plasma with antibodies from recovered COVID-19 patients to treat critically ill patients.

Singer Jon Bon Jovi paid a digital visit this week to a kindergarten class, where he helped students strengthen their songwriting skills.

The state has received a donation of hydroxychloroquine, a drug typically used to treat malaria and autoimmune diseases such as lupus that has shown promise for treating COVID-19 in critically ill patients, the Department of Consumer Protection announced Thursday. The donation from Amneal Pharmaceuticals, received with help from DCP’s Drug Control Division and the Connecticut Hospital Association, will be...

As patients with COVID-19 continue pouring into emergency departments and intensive care units across the nation, an old treatment that has been adapted for a new disease is now being tested in New York, NBC News reports.